EPRXEupraxia Pharmaceuticals Inc.
9.570CAD-3.63%Mkt Cap: 625.18M CADP/E: Last update: 2026-06-01

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug de…

Indicators:|

Key Statistics

Company
Market Cap625.18M CAD
Enterprise Value539.97M CAD
Revenue (TTM)
Gross Profit
Net Income (TTM)-38.58M CAD
Revenue/Share
Last Price9.570 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-7.83
PEG
EV/EBITDA-11.47
EV/Revenue
P/S
P/B4.11
EPS (TTM)-1.45
EPS (Forward)-1.27
52W Range
5.20057% of range12.86
52W High12.86 CAD
52W Low5.200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.02%
ROA-44.78%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-28.55M CAD
CapEx (TTM)588.95K CAD
FCF Margin
FCF Yield-2.81%
Net Debt-136.87M CAD
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity0.00
Current Ratio19.30
Quick Ratio18.95
Book Value/Sh2.414 CAD
Cash/Share2.126 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)16.00 CAD
Target Range14.00 CAD18.00 CAD
# Analysts2
Ownership
Shares Out.65.33M
Float50.32M
Insiders15.29%
Institutions45.14%
Short Interest
Short Ratio2.0d
Short % Float0.16%
Short % Out.0.13%
Shares Short86.25K
Short (prev mo.)46.84K
Technical
SMA 509.895 (-3.3%)
SMA 2009.461 (+1.2%)
Beta1.42
S&P 52W Chg27.70%
Avg Vol (30d)49.97K
Avg Vol (10d)57.92K
Technical Indicators
RSI (14)49.7
MACD-0.0168
MACD Signal-0.0505
MACD Hist.+0.0337
BB Upper11.03 CAD
BB Middle9.989 CAD
BB Lower8.952 CAD
BB Width20.76%
ATR (14)0.5740 CAD
Vol Ratio (20d)0.65x